000 04977nam a2200721Ia 4500
001 219969
003 IT-RoAPU
005 20250106150805.0
006 m|||||o||d||||||||
007 cr || ||||||||
008 240602t20202020onc fo d z eng d
020 _a9781487537982
_qPDF
024 7 _a10.3138/9781487537982
_2doi
035 _a(DE-B1597)9781487537982
035 _a(DE-B1597)570807
035 _a(OCoLC)1202479544
040 _aDE-B1597
_beng
_cDE-B1597
_erda
050 4 _aQR31.L48
_b.L489 2020
072 7 _aBIO026000
_2bisacsh
082 0 4 _a579.092
_223
084 _aonline - DeGruyter
100 1 _aLevy, Julia
_eautore
245 1 0 _aIn Sight :
_bMy Life in Science and Health Innovation /
_cJulia Levy.
264 1 _aToronto :
_bUniversity of Toronto Press,
_c[2020]
264 4 _c©2020
300 _a1 online resource (312 p.) :
_b15 b&w illustrations
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 0 _tFrontmatter --
_tContents --
_tForeword --
_t1 Waiting for the Other Shoe to Drop --
_t2 Does Your Dog Always Sit in the Front Seat? --
_t3 Where I Wanted to Be --
_t4 Life in Bed-Sits --
_t5 Woefully Outclassed --
_t6 Whose Lab Do You Work in? --
_t7 Earning My Stripes --
_t8 Seeing the Light --
_t9 Becoming Part of a Biotech Start-Up --
_t10 Positioning QLT as a Photodynamic Therapy Company --
_t11 Colleagues at American Cyanamid Come to Our Rescue --
_t12 The Nation’s Blood Supply --
_t13 PDT Is Different from Other Cancer Drugs --
_t14 I Was Surprised and Not at All Pleased --
_t15 Splitting Up --
_t16 Failure Was Never an Option --
_t17 Nothing Can Prepare You for the Torture of ODAC --
_t18 Taking Big Steps in Our AMD Clinical Trials --
_t19 An Open and Respectful Relationship --
_t20 Our Work on Age-Related Macular Degeneration Is Her Legacy --
_t21 We at QLT Were on Pins and Needles --
_t22 People Couldn’t Stop Smiling --
_t23 More Than a One-Trick Pony --
_t24 Launching the Product and Hoping for No Unpleasant Surprises --
_t25 Growing the Company --
_t26 Time to Reflect --
_t27 An Enormous Rush of Relief --
_t28 A Biotech Company with a Lot of Money Is in Danger --
_t29 I Thought These Problems Would Be Transient --
_t30 Ongoing Headaches --
_t31 He Felt Thoroughly Betrayed --
_t32 Problems with Activist Shareholders --
_t33 New Opportunity --
_tAcknowledgments --
_tAbout the Author --
_tIndex
506 0 _arestricted access
_uhttp://purl.org/coar/access_right/c_16ec
_fonline access with authorization
_2star
520 _aIn Sight is a memoir about how a love of science and discovery drove Julia Levy, a celebrated scholar and biotech CEO, to work her way through gender bias in order to achieve academic and professional recognition. Her story traces the unconventional invention of a breakthrough drug treatment from its development from laboratory research to its application as a medical treatment for vision loss. Told from a female perspective, In Sight is a unique and personal story covering Levy’s early years as a refugee, her university training in the UK, and her appointment as professor at the University of British Columbia. Years spent as an academic led the author to unexpected exposure to the biotechnology industry and a chance meeting with colleagues that led to the formation of a lucrative biotechnology company, known today as QLT Inc. The bulk of the book covers the years spent building the company, and Levy’s surprising transition from chief scientific officer to CEO. In Sight is an honest description of the trials of drug development, the tensions inherent in the commercialization of health innovations, and the truly remarkable hurdles faced by women in the scientific community.
538 _aMode of access: Internet via World Wide Web.
546 _aIn English.
588 0 _aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 02. Jun 2024)
650 0 _aChief executive officers
_zCanada
_vBiography.
650 0 _aCollege teachers
_zCanada
_vBiography.
650 0 _aMicrobiologists
_zCanada
_vBiography.
650 0 _aMicrobiology.
650 4 _aDISCOUNT-C.
650 7 _aBIOGRAPHY & AUTOBIOGRAPHY / Personal Memoirs.
_2bisacsh
653 _aIPO.
653 _aQLT.
653 _aSTEM.
653 _aVisudyne.
653 _abiography.
653 _abiotechnology.
653 _acareers.
653 _acommercialisation of science.
653 _amacular degeneration.
653 _amemoir.
653 _aphotodynamic.
653 _atherapy.
653 _awomen in business.
653 _awomen in science.
700 1 _aShoichet, Molly
_eautore
850 _aIT-RoAPU
856 4 0 _uhttps://doi.org/10.3138/9781487537982
856 4 0 _uhttps://www.degruyter.com/isbn/9781487537982
856 4 2 _3Cover
_uhttps://www.degruyter.com/document/cover/isbn/9781487537982/original
942 _cEB
999 _c219969
_d219969